We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ALRN market cap is 45.72M. The company's latest EPS is USD -0.7261 and P/E is -2.91.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.98M | -7.29M | -7.21M | -9.04M | -6.07M |
| Net Income | -1.83M | -7.34M | -7.11M | -8.94M | -5.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.96M | -20.5M | -26.61M | -27.65M | -16.28M |
| Net Income | -29.37M | -21.16M | -26.16M | -27.33M | -15.73M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.82M | 106.01M | 99.19M | 109.4M | 104.22M |
| Total Liabilities | 1.62M | 7.71M | 7.86M | 8.38M | 8.99M |
| Total Equity | 11.2M | 98.3M | 44.75M | 56.02M | 95.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.47M | 16.34M | 48.48M | 22.01M | 106.01M |
| Total Liabilities | 10.43M | 4.18M | 4.58M | 3.38M | 7.71M |
| Total Equity | 16.05M | 12.16M | 43.9M | 18.62M | 98.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.42M | -19.81M | -5.27M | -13.66M | -17.48M |
| Investing | 16.29M | 16.2M | N/A | N/A | N/A |
| Financing | N/A | 15.79M | N/A | 18.26M | 17.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.47M | -20.48M | -23.75M | -24.87M | -19.81M |
| Investing | -2.81M | 6.41M | -35.92M | 26.46M | 16.2M |
| Financing | 23.96M | 15.8M | 55.66M | N/A | 15.79M |
| Market Cap | 45.72M |
| Price to Earnings Ratio | -2.91 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.64 |
| Price to Book Ratio | 0.47 |
| Dividend Yield | - |
| Shares Outstanding | 21.67M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -55.11% |
| 52 Week High | 7.42 |
| 52 Week Low | 1.61 |
| Spread (Intraday) | 0.7 (25.93%) |
| Company Name | Aileron Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.reintx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
